Friday, September 13, 2013

British cancer patient died because of an error in the computer

27-year-old patient at the University College Hospital in London, who took part in a clinical trial with a new cancer treatment, died of a drug overdose. Because of a computer error husband gets a double dose of chemotherapy for seven procedures, reports the Sunday Times. Briton Gary Foster (Gary Foster) suffered testicular cancer. Since June 2007, he participated in a clinical study with a new method of chemotherapy called TE23, including the use of a combination of five drugs instead of three. Coordination and funding of studies involved the British Medical Research Council. In mid-September 2007, Foster attended University College Hospital in London for chemotherapy, she developed a dry cough. After some time, his condition worsened, and the patient died. The investigation revealed that. Foster's death from lung damage that was caused by an overdose of chemotherapy drug bleomycin Later it turned out that an overdose of the drug suffered another hospital patient whose life was saved. The investigation revealed that Foster received a double dose of bleomycin in seven chemotherapy. Execute the procedure nurses continued treatment under the plan, marked in the computer and ignoring the symptoms of an overdose of medication to the patient. Errors in the computer, which cost the lives of Foster, was found in the Council on Health Research for a few days before his death. In this context, the hospital e-mails with a warning. However, the sisters were able to a letter to open only a few days after the death of the patient. Currently suspended clinical trials of a new method of chemotherapy. The hospital has taken additional measures to ensure the safety of patients receiving treatment. From now on, all the protocols in the electronic system of chemotherapy carefully reviewed by experienced pharmacists, and nurses are obliged to monitor the symptoms of an overdose of drugs in patients before any re chemotherapy.

No comments:

Post a Comment